Skip to main content
. 2012 Jun;2(2):147–164. doi: 10.3978/j.issn.2223-3652.2012.06.03

Table 1. Diagnostic Utility of MR-proANP As Compared to BNP in the Biomarkers in Acute HF (BACH) Trial.

MR-proANP (>120 pmol/L) BNP (>100 pg/mL)
Sensitivity 95.56% 96.98%
Specificity 59.85% 61.90%

Adapted from: Maisel A, Mueller C, Nowak R, et al. Mid-region prohormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute HF) trail. J Am Coll Cardiol 2010;55:2062-76